Comparing the Effects of EST and EPBD in Patients With Acute Biliary Pancreatitis
Prospective Randomized Study Comparing the Effects of Endoscopic Sphincterotomy (EST) and Endoscopic Papillary Balloon Dilation (EPBD) in Patients With Acute Biliary Pancreatitis (ABP)
1 other identifier
interventional
39
1 country
1
Brief Summary
This study compares the effect of endoscopic sphincterotomy and endoscopic papillary balloon dilation in the treatment of acute biliary pancreatitis.Participants with acute biliary pancreatitis will be randomized into either the endoscopic sphincterotomy or endoscopic papillary balloon dilation groups.Moreover, the investigators compare the results obtained from the traditional bile/blood culture and metagenomics.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2016
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2016
CompletedFirst Submitted
Initial submission to the registry
January 8, 2016
CompletedFirst Posted
Study publicly available on registry
January 29, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2017
CompletedJanuary 29, 2016
January 1, 2016
1.9 years
January 8, 2016
January 26, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Complete removal of common bile duct stones
Successful bile duct clearance was defined as complete if the final cholangiogram revealed no more filling defects.
one year
Secondary Outcomes (1)
Evaluation of adverse events
One week
Study Arms (2)
Endoscopic papillary balloon dilation
EXPERIMENTALFor EPBD group, after selective cannulation of the common bile duct by the catheter, cholangiography will be performed to confirm the diagnosis of bile duct pathology. A 0.025-0.035-inch guidewire will then be inserted into the bile duct through the catheter. A dilating balloon (The controlled radial expansion (CRE) balloon dilation catheter, CRE balloon 5.5 cm (centimeter) in length, 1-1.2 cm/1.2-1.5 cm/1.5-2.0 cm in diameter) will be passed via the pre-positioned guidewire into the bile duct. Using fluoroscopic and endoscopic guidance, the balloon will be inflated with contrast medium up to the optimal size and duration (normally 5min (minutes)) after the waist on the balloon disappeared according to the patients' condition and tolerance.
Endoscopic sphincterotomy
ACTIVE COMPARATORFor EST group,endoscopic sphincterotomy(EST) will be done as large as possible with a pull type sphincterotome (The TRUEtome, Biliary sphincterotomy sphincterotome, Single-use sphincterotome CleverCut2V) Other interventions: surgical intervention, endoscopic stenting, percutaneous transhepatic cholangiogram with balloon dilation
Interventions
treatment of endoscopic papillary balloon dilation
treatment of endoscopic sphincterotomy
Eligibility Criteria
You may qualify if:
- Patients diagnosed with acute gallstone pancreatitis and fulfill any two items from a to c, plus one item in d, and e:
- abdominal pain typical of pancreatitis;
- elevation of serum amylase and/or lipase up to three times above normal;
- imaging studies (abdominal ultrasound or abdominal computed tomography) showed evidence of pancreatitis
- common bile duct stones, acute cholangitis (Charcot's triad), total bilirubin (total bilirubin)\> 4mg / dL, bile duct dilatation (diameter\> 6mm with intact gallbladder, or\> 10mm when the gallbladder has been removed) plus total bilirubin 1.8 \~ 4mg / dL;
- exclude other causes of acute pancreatitis.
You may not qualify if:
- septic shock
- serious coagulopathy (international normalized ratio 1.5, partial thromboplastin time greater than twice that of control, platelet count \<50 x 1000 / Cumm)
- malignant tumors of the biliary and pancreatic tract
- severe cardiovascular or mental illness which can not cooperate with the exam and treatment;
- pregnant women
- patient who had ever received surgery or endoscopic treatment for biliopancreatic tract
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kaohsiung Veterans General Hospital.
Kaohsiung City, 386, Taiwan
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Hoi Hung Chan, MD, PhD
Kaohsiung Veterans General Hospital.
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- associate professor
Study Record Dates
First Submitted
January 8, 2016
First Posted
January 29, 2016
Study Start
January 1, 2016
Primary Completion
December 1, 2017
Study Completion
December 1, 2017
Last Updated
January 29, 2016
Record last verified: 2016-01